IDX Lists 9 Companies in IPO Pipeline, Healthcare Sector Leads

The Indonesia Stock Exchange (IDX) recorded nine companies in its initial public offering pipeline as of October 23, 2026. The exchange disclosed the figure as part of its effort to broaden the base of listed companies in Indonesia's capital market.

"As of now, there are nine companies in IDX's listing pipeline," said Saidu Solihin, IDX's Director of Company Assessment, in an official statement in Jakarta on Friday.

Breakdown by asset scale and sector

Of the nine companies, three hold large-scale assets above Rp250 billion. Five fall into the medium category, with assets between Rp50 billion and Rp250 billion. The remaining one is classified as small scale, with assets below Rp50 billion. The classification follows Financial Services Authority (OJK) Regulation No. 53/POJK.04/2017, which sets different listing requirements based on a prospective issuer's asset size.

By sector, healthcare leads the queue with four companies. Energy and raw materials each contribute two companies, while the financial sector is represented by just one.

The healthcare sector's dominance is not surprising. Pharmaceutical firms, hospital operators, and medical device makers have been among the most active groups tapping the capital market in recent years, tracking rising healthcare demand across Indonesia.

IPO realization and IDX's 2030 target

From the start of 2026 through October 23, seven companies completed their IPOs, raising a combined Rp2.16 trillion. With these additions, the total number of listed companies on IDX now stands at 963.

IDX is targeting 1,100 listed companies by 2030. That means the exchange needs roughly 137 more new listings over the next four years, or more than 30 IPOs per year on average if the target is pursued evenly each year.

The nine companies currently in the pipeline represent only a fraction of that need. The rest will depend heavily on new prospective issuers not yet in IDX's official queue, including mid-size businesses being screened by other government agencies.

A push to widen the pool of prospective issuers

The effort to grow the number of listed companies runs alongside IDX's move to tighten IPO requirements to improve the quality of newly listed firms, as previously reported. Separately, Indonesia's Ministry of Cooperatives and SMEs has reportedly been screening 153 medium-sized businesses as potential IPO candidates.

Together, these two moves, tightening quality standards while widening the pool of candidates, illustrate how IDX is trying to balance quantity and quality of new listings as it works toward its 1,100-issuer target for 2030.

Debt securities and sukuk issuance

Beyond the equity market, IDX recorded 149 issuances from 66 issuers of debt securities and sukuk (EBUS) through October 23, 2026. EBUS covers instruments such as corporate bonds and sukuk, which companies use to raise funds without giving up equity ownership to the public. Total funds raised from these instruments reached Rp151.95 trillion, far exceeding proceeds from equity IPOs.

On top of what has already been issued, 25 more EBUS issuances from 16 issuers remain in the pipeline, spanning various business sectors. The scale of EBUS funding relative to equity IPOs suggests Indonesian corporations still lean heavily on debt markets for financing, alongside bank loans.

Rights issue activity this year

For capital raising through rights issues, a mechanism that gives existing shareholders first right to buy new shares, 16 companies completed the process as of October 23, 2026, with a combined value of Rp37.35 trillion.

One company from the property sector remains in the queue, planning to carry out a rights issue.

What it means for investors

The pipeline of nine prospective issuers is worth watching, especially its sector mix. The four healthcare companies in the queue could expand investment options in a sector where demand keeps growing in Indonesia. Investors interested in new listings should track IDX's official announcements on bookbuilding schedules and listing dates once each company publishes its prospectus.

Asset scale offers an early gauge of potential size and liquidity once a stock lists. The three companies with assets above Rp250 billion could draw more attention than the five mid-size firms or the single small-scale company, though asset size alone does not guarantee post-listing performance.

The Rp2.16 trillion raised from seven IPOs so far in 2026 can serve as a benchmark for judging this year's issuance activity against prior years, once comparable historical data becomes available. Investors can also track IDX's progress toward its 1,100-issuer target for 2030, including how far the Ministry of SMEs' screening of 153 medium-sized businesses translates into actual new listings.

What to watch next

A few things are worth monitoring in the coming months:

• Pipeline conversion: not all nine companies currently in the queue will necessarily move to listing soon. Watch for official prospectus filings in IDX's disclosure system.
• Healthcare sector: if the four healthcare issuers do list, investors can compare their valuations against healthcare companies already trading on IDX.
• Debt instruments: with Rp151.95 trillion already raised through EBUS and 25 more issuances in the queue, debt instruments look set to remain corporations' preferred funding route over new equity issuance.
• Property rights issue: the one property company still in the rights issue queue could signal capital needs within that sector.

Frequently asked questions

How many companies are in IDX's IPO pipeline as of October 2026? Nine companies were in the IPO pipeline as of October 23, 2026, consisting of three large-asset firms, five mid-size firms, and one small-asset firm.

Which sector dominates the IPO queue? Healthcare leads with four companies, followed by energy and raw materials with two each, and one from the financial sector.

How much capital has been raised from IPOs in 2026 so far? As of October 23, 2026, seven companies completed IPOs raising a combined Rp2.16 trillion.

What is IDX's target for listed companies by 2030? IDX aims to grow its listed company count from 963 currently to 1,100 by 2030.